S. Stokes

534 total citations
18 papers, 436 citations indexed

About

S. Stokes is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, S. Stokes has authored 18 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Infectious Diseases and 7 papers in Epidemiology. Recurrent topics in S. Stokes's work include Cancer therapeutics and mechanisms (8 papers), Tuberculosis Research and Epidemiology (7 papers) and Mycobacterium research and diagnosis (7 papers). S. Stokes is often cited by papers focused on Cancer therapeutics and mechanisms (8 papers), Tuberculosis Research and Epidemiology (7 papers) and Mycobacterium research and diagnosis (7 papers). S. Stokes collaborates with scholars based in United States, United Kingdom and Brazil. S. Stokes's co-authors include Adam B. Shapiro, Ed T. Buurman, Beth Andrews, Robert Albert, Ludovic R. Otterbein, Michael J. Pucci, Andrew R. McKenzie, Ning Gao, Hoan K. Huynh and Scott D. Mills and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

S. Stokes

17 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Stokes United States 12 284 163 133 85 82 18 436
Stjepan Mutak Croatia 15 213 0.8× 184 1.1× 99 0.7× 115 1.4× 64 0.8× 28 437
Evan P. Lloyd United States 11 180 0.6× 95 0.6× 123 0.9× 133 1.6× 99 1.2× 11 442
Jason L. Bowman United States 6 147 0.5× 160 1.0× 62 0.5× 38 0.4× 76 0.9× 7 389
Jan Madacki France 11 210 0.7× 165 1.0× 288 2.2× 186 2.2× 41 0.5× 14 486
Peter C. Ray United Kingdom 12 256 0.9× 162 1.0× 284 2.1× 179 2.1× 52 0.6× 21 556
Kenneth DenBleyker United States 9 138 0.5× 144 0.9× 65 0.5× 46 0.5× 55 0.7× 11 343
Gorjana Lazarevski Croatia 11 216 0.8× 151 0.9× 78 0.6× 99 1.2× 46 0.6× 24 342
Surendra Dawadi United States 13 226 0.8× 117 0.7× 115 0.9× 58 0.7× 56 0.7× 13 396
David Barros-Aguirre Spain 13 194 0.7× 102 0.6× 253 1.9× 165 1.9× 37 0.5× 19 410
Chengxin Zhi United States 11 193 0.7× 116 0.7× 71 0.5× 53 0.6× 111 1.4× 12 352

Countries citing papers authored by S. Stokes

Since Specialization
Citations

This map shows the geographic impact of S. Stokes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Stokes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Stokes more than expected).

Fields of papers citing papers by S. Stokes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Stokes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Stokes. The network helps show where S. Stokes may publish in the future.

Co-authorship network of co-authors of S. Stokes

This figure shows the co-authorship network connecting the top 25 collaborators of S. Stokes. A scholar is included among the top collaborators of S. Stokes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Stokes. S. Stokes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Cotroneo, Nicole, et al.. (2024). Efficacy of SPR720 in murine models of non-tuberculous mycobacterial pulmonary infection. Journal of Antimicrobial Chemotherapy. 79(4). 875–882. 9 indexed citations
2.
Cotroneo, Nicole, S. Stokes, Michael J. Pucci, et al.. (2022). In Vitro Resistance against DNA Gyrase Inhibitor SPR719 in Mycobacterium avium and Mycobacterium abscessus. Microbiology Spectrum. 10(1). e0132121–e0132121. 18 indexed citations
3.
Talley, Angela K., et al.. (2021). First-in-Human Evaluation of the Safety, Tolerability, and Pharmacokinetics of SPR720, a Novel Oral Bacterial DNA Gyrase (GyrB) Inhibitor for Mycobacterial Infections. Antimicrobial Agents and Chemotherapy. 65(11). e0120821–e0120821. 39 indexed citations
4.
Cotroneo, Nicole, et al.. (2020). 1274. Evaluating the Activity of SPR719, a Novel Aminobenzimidazole, against Nontuberculous Mycobacteria. Open Forum Infectious Diseases. 7(Supplement_1). S653–S654. 1 indexed citations
5.
Stokes, S., et al.. (2020). Advancement of GyrB Inhibitors for Treatment of Infections Caused by Mycobacterium tuberculosis and Non-tuberculous Mycobacteria. ACS Infectious Diseases. 6(6). 1323–1331. 28 indexed citations
6.
Deshpande, Devyani, Nicole Cotroneo, David Melnick, et al.. (2020). 1659. Pharmacokinetics/pharmacodynamics of the Novel Gyrase Inhibitor SPR719/SPR720 and Clinical Dose Selection to Treat Pulmonary Mycobacterium avium-complex Disease. Open Forum Infectious Diseases. 7(Supplement_1). S817–S817. 5 indexed citations
7.
Verma, Deepshikha, et al.. (2020). 1637. SPR720, A Novel Benzamidazole Gyrase Inhibitor, Demonstrates Potent Efficacy Against Mycobacterium avium ATCC 700898 in a Chronic C3HeBFeJ Mouse Infection Model. Open Forum Infectious Diseases. 7(Supplement_1). S809–S809. 4 indexed citations
8.
Uria-Nickelsen, Maria, Georg Neckermann, Beth Andrews, et al.. (2013). Novel topoisomerase inhibitors: microbiological characterisation and in vivo efficacy of pyrimidines. International Journal of Antimicrobial Agents. 41(4). 363–371. 24 indexed citations
9.
Murphy-Benenato, Kerry E., Hongming Wang, Helen M. McGuire, et al.. (2013). Identification through structure-based methods of a bacterial NAD+-dependent DNA ligase inhibitor that avoids known resistance mutations. Bioorganic & Medicinal Chemistry Letters. 24(1). 360–366. 10 indexed citations
10.
McKenzie, Andrew R., Adam B. Shapiro, Ludovic R. Otterbein, et al.. (2012). Inhibitors of acetyltransferase domain of N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU). Part 1: Hit to lead evaluation of a novel arylsulfonamide series. Bioorganic & Medicinal Chemistry Letters. 22(4). 1510–1519. 24 indexed citations
11.
12.
Stokes, S., et al.. (2012). New Antibacterial Agents: Patent Applications Published in 2010. Pharmaceutical Patent Analyst. 1(5). 601–620. 5 indexed citations
13.
Buurman, Ed T., Beth Andrews, Ning Gao, et al.. (2011). In Vitro Validation of Acetyltransferase Activity of GlmU as an Antibacterial Target in Haemophilus influenzae. Journal of Biological Chemistry. 286(47). 40734–40742. 39 indexed citations
14.
Stokes, S., Madhusudhan Gowravaram, Hoan K. Huynh, et al.. (2011). Discovery of bacterial NAD+-dependent DNA ligase inhibitors: Improvements in clearance of adenosine series. Bioorganic & Medicinal Chemistry Letters. 22(1). 85–89. 19 indexed citations
15.
Stokes, S., Hoan K. Huynh, Madhusudhan Gowravaram, et al.. (2011). Discovery of bacterial NAD+-dependent DNA ligase inhibitors: Optimization of antibacterial activity. Bioorganic & Medicinal Chemistry Letters. 21(15). 4556–4560. 26 indexed citations
16.
Mills, Scott D., Ann E. Eakin, Ed T. Buurman, et al.. (2010). Novel Bacterial NAD + -Dependent DNA Ligase Inhibitors with Broad-Spectrum Activity and Antibacterial Efficacy In Vivo. Antimicrobial Agents and Chemotherapy. 55(3). 1088–1096. 63 indexed citations
17.
Deak, Holly L., S. Stokes, & Marc L. Snapper. (2001). New Approach to Bicyclo [5.3.0] Ring Systems. Journal of the American Chemical Society. 123(21). 5152–5153. 25 indexed citations
18.
Raman, Prakash, et al.. (1998). Methods to Circumvent a Difficult Coupling in the Solid-Phase Synthesis of Cyclosporine Analogues. The Journal of Organic Chemistry. 63(17). 5734–5735. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stjepan Mutak Breakdown of academic impact, for papers by Evan P. Lloyd Breakdown of academic impact, for papers by Jason L. Bowman Breakdown of academic impact, for papers by Jan Madacki Breakdown of academic impact, for papers by Peter C. Ray Breakdown of academic impact, for papers by Kenneth DenBleyker Breakdown of academic impact, for papers by Gorjana Lazarevski Breakdown of academic impact, for papers by Surendra Dawadi Breakdown of academic impact, for papers by David Barros-Aguirre Breakdown of academic impact, for papers by Chengxin Zhi
Rankless by CCL
2026